✦ LIBER ✦

Transferable Vancomycin Resistance in a Community-Associated MRSA Lineage

✍ Scribed by Rossi, Flávia; Diaz, Lorena; Wollam, Aye; Panesso, Diana; Zhou, Yanjiao; Rincon, Sandra; Narechania, Apurva; Xing, Galen; Di Gioia, Thais S.R.; Doi, André; Tran, Truc T.; Reyes, Jinnethe; Munita, Jose M.; Carvajal, Lina P.; Hernandez-Roldan, Alejandra; Brandão, Denise; van der Heijden, Inneke Marie; Murray, Barbara E.; Planet, Paul J.; Weinstock, George M.; Arias, Cesar A.

Book ID: 121722691
Publisher: Massachusetts Medical Society
Year: 2014
Tongue: English
Weight: 832 KB
Volume: 370
Category: Article
ISSN: 0096-6762
DOI: 10.1056/NEJMoa1303359

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro exposure of community-associate

In vitro exposure of community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains to vancomycin: does vancomycin resistance occur?

✍ Sharon L. Kleinschmidt; Wendy J. Munckhof; Graeme R. Nimmo 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Glycopeptide and daptomycin resistance i

Glycopeptide and daptomycin resistance in community-associated MRSA in the UK

✍ A. Kirby; C. Edwards; C. M. Broughton; N. J. Williams 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 214 KB

Community-associated methicillin-resista

Community-associated methicillin-resistant Staphylococcus aureus (MRSA) in Australia

✍ Graeme R. Nimmo; Geoffrey W. Coombs 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 622 KB

Virulence strategies of the dominant USA

Virulence strategies of the dominant USA300 lineage of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)

✍ Lance R. Thurlow; Gauri S. Joshi; Anthony R. Richardson 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 553 KB

Lack of community-associated MRSA in Rom

Lack of community-associated MRSA in Rome

✍ G.B. Orsi; C.M. Mastroianni; A. Giordano; M. Monaco; M. Venditti 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB

In vitro activity of oritavancin against

In vitro activity of oritavancin against community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA)

✍ Louis D. Saravolatz; Joan Pawlak; Leonard B. Johnson 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 120 KB